 Sanda Predescu
Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adaptor Proteins, Vesicular Transport | 12 | 2017 | 41 | 5.530 |
Why?
| | Endothelial Cells | 15 | 2020 | 66 | 3.900 |
Why?
| | Pulmonary Artery | 3 | 2020 | 60 | 2.220 |
Why?
| | Lung | 12 | 2017 | 169 | 2.220 |
Why?
| | Hypertension, Pulmonary | 4 | 2020 | 26 | 2.190 |
Why?
| | Caveolae | 7 | 2015 | 18 | 1.700 |
Why?
| | Endocytosis | 7 | 2015 | 20 | 1.700 |
Why?
| | Capillary Permeability | 6 | 2013 | 28 | 1.240 |
Why?
| | Mice | 17 | 2021 | 1843 | 1.220 |
Why?
| | Cell Membrane | 5 | 2013 | 129 | 1.180 |
Why?
| | Animals | 23 | 2021 | 5221 | 1.120 |
Why?
| | Sex Characteristics | 2 | 2021 | 126 | 1.010 |
Why?
| | Cell Proliferation | 4 | 2020 | 238 | 0.980 |
Why?
| | RNA, Small Interfering | 6 | 2017 | 72 | 0.960 |
Why?
| | RNA, Long Noncoding | 1 | 2021 | 3 | 0.910 |
Why?
| | rac1 GTP-Binding Protein | 3 | 2016 | 14 | 0.890 |
Why?
| | Disease Models, Animal | 3 | 2021 | 831 | 0.850 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 2 | 2015 | 18 | 0.730 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 2 | 2015 | 23 | 0.730 |
Why?
| | MAP Kinase Signaling System | 2 | 2019 | 44 | 0.710 |
Why?
| | ets-Domain Protein Elk-1 | 2 | 2017 | 5 | 0.710 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2017 | 41 | 0.700 |
Why?
| | Vascular Remodeling | 1 | 2017 | 9 | 0.680 |
Why?
| | Lung Diseases | 1 | 2017 | 55 | 0.670 |
Why?
| | Endothelium, Vascular | 7 | 2015 | 74 | 0.670 |
Why?
| | SOS1 Protein | 1 | 2016 | 5 | 0.660 |
Why?
| | Proto-Oncogene Proteins c-cbl | 1 | 2016 | 15 | 0.660 |
Why?
| | Receptors, G-Protein-Coupled | 3 | 2013 | 27 | 0.640 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2016 | 93 | 0.620 |
Why?
| | Enzyme Activation | 2 | 2013 | 144 | 0.620 |
Why?
| | Smad2 Protein | 1 | 2015 | 3 | 0.600 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2015 | 12 | 0.590 |
Why?
| | Platelet Membrane Glycoproteins | 2 | 2013 | 7 | 0.570 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2013 | 17 | 0.560 |
Why?
| | Ceramides | 1 | 2013 | 13 | 0.540 |
Why?
| | Apoptosis | 3 | 2015 | 291 | 0.540 |
Why?
| | Liposomes | 1 | 2013 | 24 | 0.530 |
Why?
| | Lung Neoplasms | 2 | 2017 | 753 | 0.530 |
Why?
| | Dynamin II | 1 | 2011 | 2 | 0.480 |
Why?
| | Cells, Cultured | 7 | 2020 | 791 | 0.470 |
Why?
| | Mice, Knockout | 5 | 2021 | 384 | 0.450 |
Why?
| | Down-Regulation | 1 | 2011 | 132 | 0.430 |
Why?
| | Humans | 19 | 2021 | 30741 | 0.420 |
Why?
| | Actins | 2 | 2009 | 62 | 0.420 |
Why?
| | Gene Knockdown Techniques | 3 | 2015 | 44 | 0.410 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2009 | 5 | 0.410 |
Why?
| | Qb-SNARE Proteins | 2 | 2005 | 4 | 0.380 |
Why?
| | Qc-SNARE Proteins | 2 | 2005 | 4 | 0.380 |
Why?
| | Microscopy, Fluorescence | 5 | 2013 | 111 | 0.370 |
Why?
| | Microscopy, Electron | 5 | 2013 | 100 | 0.360 |
Why?
| | Exocytosis | 1 | 2007 | 11 | 0.350 |
Why?
| | Rats | 4 | 2019 | 954 | 0.340 |
Why?
| | Mitochondria | 1 | 2007 | 87 | 0.330 |
Why?
| | Qa-SNARE Proteins | 1 | 2005 | 4 | 0.310 |
Why?
| | Cholesterol | 1 | 2005 | 65 | 0.300 |
Why?
| | Membrane Fusion | 1 | 2005 | 62 | 0.300 |
Why?
| | Cell Line | 3 | 2015 | 354 | 0.290 |
Why?
| | Carrier Proteins | 1 | 2003 | 130 | 0.250 |
Why?
| | Protein Structure, Tertiary | 3 | 2013 | 87 | 0.250 |
Why?
| | Platelet Activating Factor | 2 | 2013 | 8 | 0.230 |
Why?
| | Neuropeptides | 2 | 2013 | 26 | 0.230 |
Why?
| | Male | 8 | 2021 | 17552 | 0.230 |
Why?
| | RNA, Messenger | 2 | 2013 | 361 | 0.220 |
Why?
| | Indoles | 2 | 2019 | 68 | 0.210 |
Why?
| | Up-Regulation | 1 | 2021 | 218 | 0.210 |
Why?
| | Signal Transduction | 3 | 2015 | 582 | 0.200 |
Why?
| | Pyrroles | 1 | 2019 | 27 | 0.190 |
Why?
| | Biotin | 2 | 2011 | 8 | 0.190 |
Why?
| | Lung Injury | 3 | 2013 | 7 | 0.180 |
Why?
| | Intercellular Junctions | 2 | 2008 | 9 | 0.170 |
Why?
| | Systole | 1 | 2017 | 23 | 0.170 |
Why?
| | Transduction, Genetic | 1 | 2017 | 22 | 0.170 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2017 | 26 | 0.170 |
Why?
| | Hypertrophy | 1 | 2017 | 20 | 0.170 |
Why?
| | Time-Lapse Imaging | 1 | 2016 | 10 | 0.170 |
Why?
| | Neoplasm Transplantation | 1 | 2016 | 25 | 0.170 |
Why?
| | Ubiquitination | 1 | 2016 | 15 | 0.170 |
Why?
| | Lipids | 1 | 2017 | 55 | 0.160 |
Why?
| | Collagen | 1 | 2017 | 111 | 0.160 |
Why?
| | Neoplasm Metastasis | 1 | 2016 | 148 | 0.160 |
Why?
| | Cell Movement | 1 | 2016 | 117 | 0.160 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2016 | 135 | 0.160 |
Why?
| | Caveolin 1 | 2 | 2005 | 10 | 0.150 |
Why?
| | Scavenger Receptors, Class B | 1 | 2015 | 3 | 0.150 |
Why?
| | Disease Progression | 1 | 2019 | 851 | 0.150 |
Why?
| | alpha 1-Antitrypsin | 1 | 2015 | 4 | 0.150 |
Why?
| | Immunoblotting | 2 | 2013 | 66 | 0.150 |
Why?
| | Phosphorylation | 2 | 2013 | 196 | 0.150 |
Why?
| | Cell Line, Tumor | 1 | 2016 | 296 | 0.150 |
Why?
| | Nitric Oxide | 3 | 2005 | 108 | 0.150 |
Why?
| | Heart Ventricles | 1 | 2017 | 220 | 0.150 |
Why?
| | Transfection | 2 | 2013 | 153 | 0.150 |
Why?
| | Nitric Oxide Synthase Type II | 3 | 2011 | 70 | 0.140 |
Why?
| | Cell Survival | 1 | 2015 | 182 | 0.140 |
Why?
| | Smoking | 1 | 2015 | 197 | 0.140 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2013 | 32 | 0.130 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2013 | 12 | 0.130 |
Why?
| | Granzymes | 1 | 2013 | 8 | 0.130 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 3 | 0.130 |
Why?
| | Proteolysis | 1 | 2013 | 19 | 0.130 |
Why?
| | Cations | 1 | 2013 | 16 | 0.130 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2013 | 11 | 0.130 |
Why?
| | Endothelium | 1 | 2013 | 15 | 0.130 |
Why?
| | Gene Silencing | 1 | 2013 | 26 | 0.130 |
Why?
| | Gene Deletion | 1 | 2013 | 57 | 0.130 |
Why?
| | Female | 3 | 2021 | 18107 | 0.130 |
Why?
| | Models, Animal | 1 | 2013 | 150 | 0.130 |
Why?
| | Analysis of Variance | 1 | 2013 | 369 | 0.120 |
Why?
| | Mice, Transgenic | 1 | 2013 | 301 | 0.120 |
Why?
| | Immunohistochemistry | 1 | 2013 | 501 | 0.120 |
Why?
| | src Homology Domains | 1 | 2011 | 3 | 0.120 |
Why?
| | Clathrin | 1 | 2011 | 4 | 0.120 |
Why?
| | GTP Phosphohydrolases | 1 | 2011 | 5 | 0.120 |
Why?
| | Phenotype | 1 | 2013 | 368 | 0.120 |
Why?
| | Heat-Shock Proteins | 1 | 2011 | 10 | 0.110 |
Why?
| | Calcification, Physiologic | 1 | 2011 | 21 | 0.110 |
Why?
| | Skull | 1 | 2011 | 25 | 0.110 |
Why?
| | Lipopolysaccharides | 1 | 2011 | 138 | 0.110 |
Why?
| | Blotting, Western | 1 | 2011 | 235 | 0.110 |
Why?
| | Osteoblasts | 1 | 2011 | 62 | 0.110 |
Why?
| | Extracellular Matrix | 1 | 2011 | 90 | 0.110 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 209 | 0.110 |
Why?
| | Cell Differentiation | 1 | 2011 | 171 | 0.100 |
Why?
| | Wiskott-Aldrich Syndrome Protein | 1 | 2009 | 2 | 0.100 |
Why?
| | Actin-Related Protein 2-3 Complex | 1 | 2009 | 2 | 0.100 |
Why?
| | Pseudopodia | 1 | 2009 | 5 | 0.100 |
Why?
| | Cadherins | 2 | 2008 | 37 | 0.100 |
Why?
| | rac GTP-Binding Proteins | 1 | 2008 | 4 | 0.100 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2008 | 10 | 0.100 |
Why?
| | Inflammation | 1 | 2011 | 345 | 0.090 |
Why?
| | Nitric Oxide Synthase | 2 | 2005 | 48 | 0.090 |
Why?
| | Mice, Inbred C57BL | 4 | 2015 | 538 | 0.090 |
Why?
| | Biological Transport | 1 | 2007 | 47 | 0.090 |
Why?
| | Cytochromes c | 1 | 2007 | 15 | 0.090 |
Why?
| | In Situ Nick-End Labeling | 1 | 2007 | 18 | 0.090 |
Why?
| | Receptors, Lysophospholipid | 1 | 2007 | 1 | 0.090 |
Why?
| | Base Sequence | 1 | 2007 | 162 | 0.080 |
Why?
| | Albumins | 2 | 2005 | 36 | 0.080 |
Why?
| | Monocytes | 1 | 2007 | 105 | 0.080 |
Why?
| | Cell-Free System | 1 | 2005 | 3 | 0.080 |
Why?
| | Streptavidin | 1 | 2005 | 4 | 0.080 |
Why?
| | GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2005 | 3 | 0.080 |
Why?
| | SNARE Proteins | 1 | 2005 | 14 | 0.080 |
Why?
| | Vesicular Transport Proteins | 1 | 2005 | 9 | 0.080 |
Why?
| | Microscopy, Immunoelectron | 1 | 2003 | 6 | 0.070 |
Why?
| | Cell Compartmentation | 1 | 2003 | 12 | 0.070 |
Why?
| | Dynamins | 1 | 2003 | 15 | 0.070 |
Why?
| | Cloning, Molecular | 1 | 2003 | 43 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 149 | 0.060 |
Why?
| | Models, Molecular | 1 | 2003 | 103 | 0.060 |
Why?
| | Chemokines | 1 | 2002 | 28 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 1 | 2003 | 489 | 0.060 |
Why?
| | Sepsis | 1 | 2002 | 155 | 0.050 |
Why?
| | Phosphoproteins | 2 | 2011 | 36 | 0.050 |
Why?
| | Protein Binding | 2 | 2011 | 156 | 0.050 |
Why?
| | Antigens, CD | 2 | 2008 | 107 | 0.040 |
Why?
| | Brain | 1 | 2007 | 1574 | 0.040 |
Why?
| | NG-Nitroarginine Methyl Ester | 2 | 2005 | 7 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2015 | 30 | 0.040 |
Why?
| | Integrases | 1 | 2013 | 3 | 0.030 |
Why?
| | Enzyme Stability | 1 | 2013 | 6 | 0.030 |
Why?
| | Gene Expression Regulation | 2 | 2007 | 348 | 0.030 |
Why?
| | Mutation | 2 | 2007 | 457 | 0.030 |
Why?
| | Body Fluids | 1 | 2013 | 21 | 0.030 |
Why?
| | Organ Specificity | 1 | 2013 | 57 | 0.030 |
Why?
| | Collagen Type I | 1 | 2011 | 19 | 0.030 |
Why?
| | Calcium Phosphates | 1 | 2011 | 30 | 0.030 |
Why?
| | Endoplasmic Reticulum | 1 | 2011 | 41 | 0.030 |
Why?
| | Extracellular Matrix Proteins | 1 | 2011 | 177 | 0.030 |
Why?
| | Myosin Light Chains | 1 | 2008 | 6 | 0.020 |
Why?
| | Zonula Occludens-1 Protein | 1 | 2008 | 18 | 0.020 |
Why?
| | Protein Transport | 1 | 2008 | 42 | 0.020 |
Why?
| | Retroviridae | 1 | 2007 | 8 | 0.020 |
Why?
| | Lysophosphatidylcholines | 1 | 2007 | 7 | 0.020 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2007 | 12 | 0.020 |
Why?
| | Luminescent Measurements | 1 | 2007 | 21 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2008 | 211 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2007 | 175 | 0.020 |
Why?
| | Coloring Agents | 1 | 2005 | 16 | 0.020 |
Why?
| | Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins | 1 | 2005 | 1 | 0.020 |
Why?
| | Umbilical Veins | 1 | 2005 | 3 | 0.020 |
Why?
| | Glycerol | 1 | 2005 | 3 | 0.020 |
Why?
| | Two-Hybrid System Techniques | 1 | 2005 | 7 | 0.020 |
Why?
| | Blood Vessels | 1 | 2005 | 19 | 0.020 |
Why?
| | Glutathione Transferase | 1 | 2005 | 8 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 2005 | 25 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2005 | 56 | 0.020 |
Why?
| | COS Cells | 1 | 2005 | 47 | 0.020 |
Why?
| | Plasmids | 1 | 2005 | 53 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2005 | 127 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2005 | 252 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2005 | 160 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2005 | 316 | 0.020 |
Why?
| | Gold Colloid | 1 | 2002 | 2 | 0.020 |
Why?
| | Nitrates | 1 | 2002 | 9 | 0.020 |
Why?
| | Biological Transport, Active | 1 | 2002 | 20 | 0.020 |
Why?
| | Tyrosine | 1 | 2002 | 26 | 0.020 |
Why?
| | Cross-Linking Reagents | 1 | 2002 | 17 | 0.020 |
Why?
| | Chemokine CXCL2 | 1 | 2002 | 2 | 0.020 |
Why?
| | Nitric Oxide Donors | 1 | 2002 | 7 | 0.020 |
Why?
| | Perfusion | 1 | 2002 | 23 | 0.020 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2002 | 16 | 0.020 |
Why?
| | Escherichia coli Infections | 1 | 2002 | 32 | 0.020 |
Why?
| | Pulmonary Edema | 1 | 2002 | 14 | 0.020 |
Why?
| | Binding Sites | 1 | 2002 | 95 | 0.020 |
Why?
| | NF-kappa B | 1 | 2002 | 108 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2002 | 298 | 0.010 |
Why?
| | Inflammation Mediators | 1 | 2002 | 91 | 0.010 |
Why?
| | Neutrophils | 1 | 2002 | 127 | 0.010 |
Why?
| | Myocardium | 1 | 2002 | 180 | 0.010 |
Why?
|
|
Predescu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|